Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120689242 | 12068924 | 2 | F | 20141108 | 20160203 | 20160211 | 20160825 | EXP | ES-AGEMED-409352344 | ES-DSJP-DSE-2016-104905 | DAIICHI | 81.00 | YR | F | Y | 0.00000 | 20160825 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120689242 | 12068924 | 1 | PS | SEVIKAR HCT 20 mg/5 mg/12,5 mg | AMLODIPINE BESYLATEHYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | Oral | 40/10/25 MG, QD | 50 | DF | Y | 200175 | 2 | DF | FILM-COATED TABLET | QD | |||
| 120689242 | 12068924 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 120689242 | 12068924 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 50 ?G, QD | 0 | 50 | UG | QD | |||||||
| 120689242 | 12068924 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 120689242 | 12068924 | 5 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 50 MG, BID | 0 | 50 | MG | BID | |||||||
| 120689242 | 12068924 | 6 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | Oral | 4 MG, QD | 0 | 4 | MG | TABLET | QD | ||||||
| 120689242 | 12068924 | 7 | C | PAZITAL | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 120689242 | 12068924 | 8 | C | TARGIN | NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE | 1 | Oral | 10/5 MG, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120689242 | 12068924 | 1 | Hypertension |
| 120689242 | 12068924 | 2 | Hypertension |
| 120689242 | 12068924 | 3 | Hypothyroidism |
| 120689242 | 12068924 | 4 | Dyslipidaemia |
| 120689242 | 12068924 | 5 | Hypertension |
| 120689242 | 12068924 | 6 | Hypertension |
| 120689242 | 12068924 | 7 | Product used for unknown indication |
| 120689242 | 12068924 | 8 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120689242 | 12068924 | HO |
| 120689242 | 12068924 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120689242 | 12068924 | Bradyphrenia | |
| 120689242 | 12068924 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120689242 | 12068924 | 1 | 20141015 | 20141108 | 0 | |
| 120689242 | 12068924 | 2 | 20141015 | 0 | ||
| 120689242 | 12068924 | 3 | 20140804 | 0 | ||
| 120689242 | 12068924 | 4 | 20140911 | 0 | ||
| 120689242 | 12068924 | 5 | 20141015 | 0 | ||
| 120689242 | 12068924 | 6 | 20141015 | 0 | ||
| 120689242 | 12068924 | 7 | 1990 | 0 | ||
| 120689242 | 12068924 | 8 | 20140703 | 0 |